https://www.selleckchem.com/products/lji308.html
Magnetic resonance/ ultrasound fusion targeted biopsy (Tbs) is widely used for diagnosing prostate cancer (PCa).The aim of our study was to compare the cancer detection rate (CDR) and the clinically significant prostate cancer detectionrate (csPCa) of the magnetic resonance/ultrasound fusion targeted biopsy with those of the standard systematic biopsy (Sbs)and of the combination of both techniques. A total of 182 patients underwent magnetic resonance/ultrasound fusion Tbs on the prostate for PCa suspicion based on multiparametric magneti
Like
Comment
Share
